Table 5 Pharmacological, conservative non-pharmacological, and surgical therapies used by people with HKOA with UPL or MPL
| Â | Total | UPL | MPL | p-valuea |
|---|---|---|---|---|
Sample size and weighted prevalence n(%) | n = 1035 (100) | n = 765 (68.4) | N = 270 (31.6) |  |
Pharmacological therapies | Â | Â | Â | |
Anti-inflammatory | Â | Â | Â | Â |
NSAIDS, n (%) | 239 (19.0) | 194 (22.0) | 45 (12.5) | 0.003 |
Topical NSAIDS, n (%) | 10 (1.2) | 7 (1.5) | 3 (0.7) | 0.410 |
Opioids | Â | Â | Â | Â |
Simple opioids, n (%) | 49 (3.7) | 44 (4.8) | 5 (1.3) | 0.008 |
Opioids combined with analgesics, n (%) | 24 (1.4) | 22 (1.8) | 2 (0.4) | 0.053 |
Analgesics/antipyretics | Â | Â | Â | Â |
Analgesics (all), n (%) | 72 (5.7) | 62 (7.3) | 10 (2.7) | 0.013 |
Paracetamol, n (%) | 25 (2.0) | 23 (2.7) | 2 (0.6) | 0.033 |
Others | Â | Â | Â | Â |
Glucosamine, n (%) | 65 (4.7) | 53 (5.1) | 12 (3.9) | 0.438 |
Conservative non-pharmacological therapies | ||||
Physiotherapy, n (%) | 152 (14.9) | 121 (17.5) | 31 (8.9) | 0.002 |
Surgery | ||||
Hip surgeryb, n (%) | 42 (18.7) | 29 (19.1) | 13 (17.6) | 0.847 |
Knee surgeryc, n (%) | 113 (13.2) | 82 (13.4) | 31 (13.0) | 0.893 |